The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Expression of Cyclin-Dependent Kinase Inhibitors in Vascular Disease
Open accessAbstract
Abstract —Arterial lesions in cardiovascular diseases are characterized by proliferation and migration of smooth muscle cells as well as deposition of connective tissue matrix. Factors that stimulate vascular smooth muscle cell (VSMC) proliferation are well described; however, the role of proteins that limit intimal hyperplasia is not well understood. To examine the function of Kip/Cip and INK cyclin-dependent kinase inhibitors (CKIs) in vascular diseases, the expression of p27 Kip1 and p16 INK was examined in VSMCs in vitro and in porcine arteries and human atherosclerosis in vivo. Western blot and fluorescence activated cell-sorting analysis demonstrated that levels of p27 Kip1 , but not p16 INK , increased during serum deprivation of primary VSMC cultures and caused G 1 arrest. p27 Kip1 inhibited Cdk2 activity, suggesting that Kip CKIs promote G 1 arrest in VSMCs by binding cyclin E/Cdk2. In porcine arteries, p27 Kip1 , but not p16 INK , was constitutively expressed at low levels. Immediately after balloon injury, cell proliferation increased as p27 Kip1 levels declined. Three weeks after injury, p27 Kip1 was strongly expressed in intimal VSMCs when VSMC proliferation was <2%, suggesting that p27 Kip1 functions as an inhibitor of cell proliferation in injured arteries. In contrast, p16 INK expression was detected only transiently early after injury. CKI expression was examined in 35 human coronary arteries, ranging from normal to advanced atherosclerosis. p27 Kip1 expression was abundant in nonproliferating VSMCs and macrophages within normal (7 of 8) and atherosclerotic (25 of 27) arteries. p21 Cip1 levels were undetectable in normal arteries but were elevated in atherosclerotic (19 of 27) arteries. p16 INK could not be detected in normal or atherosclerotic arteries (0 of 35). Thus, the Kip/Cip and INK CKIs have different temporal patterns of expression in VSMCs in vitro and in injured arteries and atherosclerotic lesions in vivo. In contrast to p16 INK , p27 Kip1 likely contributes to the remodeling process in vascular diseases by the arrest of VSMCs in the G 1 phase of the cell cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Cited by
Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Heme oxygenase-1 protects against vascular constriction and proliferation
Duckers, H. J., Boehm, M., True, A. L., Yet, S.-F., San, H., Park, J. L., Clinton Webb, R., Lee, M.-E., Nabel, G. J., & Nabel, E. G. (2001) · Nature Medicine · doi:10.1038/89068 · Cited by 525
Self-citationMolecular Basis of Restenosis and Drug-Eluting Stents
Costa, M. A., & Simon, D. I. (2005) · Circulation · doi:10.1161/01.cir.0000163587.36485.a7 · Cited by 510
Mechanisms of controlled drug release from drug-eluting stents
Acharya, G., & Park, K. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.016 · Cited by 363
Autophagy in cardiovascular biology
Lavandero, S., Chiong, M., Rothermel, B. A., & Hill, J. A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73943 · Cited by 331
Metadata
- Authors
- Tanner, F. C., Yang, Z.-Y., Duckers, E., Gordon, D., Nabel, G. J., & Nabel, E. G.
- Venue
- Circulation Research
- Published
- 1998-02-23
- Volume
- 82
- Issue
- 3
- Pages
- 396-403
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2104576349
- Cited by
- 253
- References
- 32
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of Cyclin-Dependent Kinase Inhibitors in Vascular Disease. https://app.cochat.ai/papers/10.1161/01.res.82.3.396
- The paper
- Tanner, F. C., Yang, Z.-Y., Duckers, E., Gordon, D., Nabel, G. J., & Nabel, E. G. (1998). Expression of Cyclin-Dependent Kinase Inhibitors in Vascular Disease. Circulation Research. https://doi.org/10.1161/01.res.82.3.396
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.